关于我们

Changzhou HJCC Biotech Co.,Ltd is a biotechnology enterprise specializing in the research and development, production, and application of antibody reagents. Antibodies, as precise probes of the immune system, are the core tools of modern biomedical research, widely used in drug target validation, disease mechanism research, in vitro diagnostic development, and therapeutic antibody screening. The company relies on advanced hybridoma technology and recombinant antibody platform to build an antibody product line covering the entire species. We have developed tens of thousands of high-quality antibodies and related products, including nanobodies, mouse monoclonal antibodies, recombinant rabbit monoclonal antibodies, enzyme-linked immunosorbent assay (ELISA) kits, multiplex immunohistochemistry kits, cell-based ELISA kits, etc. We are committed to providing highly specific and affinity antibody reagents for global research institutions, pharmaceutical companies, and diagnostic companies, becoming a reliable partner to support the development of basic scientific research and translational medicine.

The company has established a quality control system covering the entire process of research and development, production, and validation. Each batch of antibodies has been rigorously validated through application experiments such as WB, IHC, IF, and FC. Our technical team continues to promote innovation in antibody technology, focusing on the development of nanobodies, mouse monoclonal antibodies, recombinant rabbit monoclonal antibodies and other products, while providing one-stop services from antigen design to antibody customization. By continuously optimizing the expression system and purification process, we ensure that our products achieve industry-leading levels of inter batch consistency and long-term stability, helping users obtain reliable and reproducible experimental data.